Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-018187
Filing Date
2020-04-23
Accepted
2020-04-23 16:05:27
Documents
3
Period of Report
2020-06-17
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A hrtx-def14a_20200617.htm DEF 14A 1504315
2 GRAPHIC g4kmdyhvmp54000001.jpg GRAPHIC 47568
3 GRAPHIC g4kmdyhvmp54000002.jpg GRAPHIC 48117
  Complete submission text file 0001564590-20-018187.txt   1637610
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 20811054
SIC: 2834 Pharmaceutical Preparations